COINFECTION WITH A-TYPE AND B-TYPE EPSTEIN-BARR-VIRUS IN HUMAN-IMMUNODEFICIENCY-VIRUS POSITIVE SUBJECTS

被引:118
作者
SCULLEY, TB
APOLLONI, A
HURREN, L
MOSS, DJ
COOPER, DA
机构
[1] ST VINCENTS HOSP,CTR IMMUNOL,SYDNEY,NSW 2010,AUSTRALIA
[2] UNIV NEW S WALES,NHMRC SPECIAL UNIT AIDS EPIDEMIOL & CLIN RES,KENSINGTON,NSW 2033,AUSTRALIA
基金
英国医学研究理事会;
关键词
D O I
10.1093/infdis/162.3.642
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A possible cofactor in human immunodeficiency virus (HIV) infection is the Epstein-Barr virus (EBV), which is divided into two primary types that differ significantly in their transformation efficiency. The B-type EBV cell line is much more difficult to establish than the A-type. The extent of systemic B-type EBV infection was assessed in HIV-positive subjects and controls. Lymphoblastoid cell lines were established from 26 HIV-positive subjects and analyzed for the presence of A- or B-type EBV by Southern analysis and immunoblotting. Some 19% of HIV-positive persons were infected with B-type EBV, 69% with A-type, and 12% with both types. Analysis of the individual strains of EBV harbored by the HIV-positive subjects showed that HIV-induced immunosuppression had not led to increased susceptibility to repeated EBV infections. However, the occurrence of B-type infection in HIV-positive subjects was sixfold higher than that in the general community, indicating that HIV-induced immunodeficiency or HIV itself specifically enhanced the expression of the B-type EBV. © 1990, by The University of Chicago.
引用
收藏
页码:643 / 648
页数:6
相关论文
共 28 条
[1]   A PUTATIVE TRANSFORMING GENE OF JIJOYE VIRUS DIFFERS FROM THAT OF EPSTEIN-BARR VIRUS PROTOTYPES [J].
ADLDINGER, HK ;
DELIUS, H ;
FREESE, UK ;
CLARKE, J ;
BORNKAMM, GW .
VIROLOGY, 1985, 141 (02) :221-234
[2]  
BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5
[3]   ANTIBODY-RESPONSE TO HUMAN-IMMUNODEFICIENCY-VIRUS AFTER PRIMARY INFECTION [J].
COOPER, DA ;
IMRIE, AA ;
PENNY, R .
JOURNAL OF INFECTIOUS DISEASES, 1987, 155 (06) :1113-1118
[4]  
CRAWFORD DH, 1984, BRIT J VENER DIS, V60, P258
[5]   DIFFERENCES AMONG HUMAN IMMUNODEFICIENCY VIRUS-STRAINS IN THEIR CAPACITIES TO INDUCE CYTOLYSIS OR PERSISTENT INFECTION OF A LYMPHOBLASTOID CELL-LINE IMMORTALIZED BY EPSTEIN-BARR-VIRUS [J].
DAHL, K ;
MARTIN, K ;
MILLER, G .
JOURNAL OF VIROLOGY, 1987, 61 (05) :1602-1608
[6]   FREQUENT DETECTION AND ISOLATION OF CYTOPATHIC RETROVIRUSES (HTLV-III) FROM PATIENTS WITH AIDS AND AT RISK FOR AIDS [J].
GALLO, RC ;
SALAHUDDIN, SZ ;
POPOVIC, M ;
SHEARER, GM ;
KAPLAN, M ;
HAYNES, BF ;
PALKER, TJ ;
REDFIELD, R ;
OLESKE, J ;
SAFAI, B ;
WHITE, G ;
FOSTER, P ;
MARKHAM, PD .
SCIENCE, 1984, 224 (4648) :500-503
[7]   RELATION OF ORAL HAIRY LEUKOPLAKIA TO INFECTION WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS AND THE RISK OF DEVELOPING AIDS [J].
GREENSPAN, D ;
GREENSPAN, JS ;
HEARST, NG ;
PAN, LZ ;
CONANT, MA ;
ABRAMS, DI ;
HOLLANDER, H ;
LEVY, JA .
JOURNAL OF INFECTIOUS DISEASES, 1987, 155 (03) :475-481
[8]  
GRUTARMA JW, 1988, P NATL ACAD SCI USA, V85, P8693
[9]   SEROIMMUNOLOGY OF AIDS RETROVIRUS INFECTION .1. USE OF IMMUNOFLUORESCENCE ASSAY TO CONFIRM SERA WITH ELISA REACTIVITY [J].
IMRIE, AA ;
KEHRER, S ;
SMITH, GW ;
PENNY, R ;
COOPER, DA .
PATHOLOGY, 1986, 18 (04) :438-443
[10]   AN EPSTEIN-BARR VIRUS IMMEDIATE-EARLY GENE-PRODUCT TRANS-ACTIVATES GENE-EXPRESSION FROM THE HUMAN IMMUNODEFICIENCY VIRUS LONG TERMINAL REPEAT [J].
KENNEY, S ;
KAMINE, J ;
MARKOVITZ, D ;
FENRICK, R ;
PAGANO, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (05) :1652-1656